{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:00:27Z","timestamp":1793754027316,"version":"4.6.1"},"reference-count":78,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T00:00:00Z","timestamp":1317686400000},"content-version":"vor","delay-in-days":64,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:p>\n                    The strict human pathogen\n                    <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                    has caused gonorrhea for thousands of years, and currently gonorrhea is the second most prevalent bacterial sexually transmitted infection worldwide. Given the ancient nature of\n                    <jats:italic>N. gonorrhoeae<\/jats:italic>\n                    and its unique obligate relationship with humankind over the millennia, its remarkable ability to adapt to the host immune system and cause repeated infections, and its propensity to develop resistance to all clinically useful antibiotics, the gonococcus is an ideal pathogen on which to study the evolution of bacterial pathogenesis, including antimicrobial resistance, over the long term and within the host during infection. Recently, the first gonococcus displaying high\u2010level resistance to ceftriaxone, identified in Japan, was characterized in detail. Ceftriaxone is the last remaining option for empirical first\u2010line treatment, and\n                    <jats:italic>N. gonorrhoeae<\/jats:italic>\n                    now seems to be evolving into a true \u201csuperbug.\u201d In the near future, gonorrhea may become untreatable in certain circumstances. Herein, the history of antibiotics used for treatment of gonorrhea, the evolution of resistance emergence in\n                    <jats:italic>N. gonorrhoeae<\/jats:italic>\n                    , the linkage between resistance and biological fitness of\n                    <jats:italic>N. gonorrhoeae<\/jats:italic>\n                    , lessons learned, and future perspectives are reviewed and discussed.\n                  <\/jats:p>","DOI":"10.1111\/j.1749-6632.2011.06215.x","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T20:44:33Z","timestamp":1317761073000},"source":"Crossref","is-referenced-by-count":211,"title":["Antibiotic resistance in\n                    <i>Neisseria gonorrhoeae<\/i>\n                    : origin, evolution, and lessons learned for the future"],"prefix":"10.1111","volume":"1230","author":[{"given":"Magnus","family":"Unemo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,4]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1586\/eri.09.63"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1970.03170140047006"},{"key":"e_1_2_7_4_2","first-page":"607","volume-title":"Sexually Transmitted Diseases.","author":"Sparling P.F.","year":"2007"},{"key":"e_1_2_7_5_2","volume-title":"Neisseria: Molecular Mechanisms of Pathogenesis","author":"Shafer W.M.","year":"2010"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-198304000-00007"},{"key":"e_1_2_7_7_2","first-page":"81","article-title":"Gonorrhoea and the sulphonamides","volume":"25","author":"Dunlop E.M.C.","year":"1949","journal-title":"Br. J. Vener. Dis."},{"key":"e_1_2_7_8_2","first-page":"525","article-title":"The use of penicillin sodium in the treatment of sulfonamide\u2010resistant gonorrhea in men. A preliminary report","volume":"27","author":"Mahoney J.F.","year":"1943","journal-title":"Am. J. Gonorr. Vener. Dis."},{"key":"e_1_2_7_9_2","first-page":"217","article-title":"A survey of problems in the antibiotic treatment of gonorrhoea. With special reference to South\u2010East Asia","volume":"46","author":"Willcox R.R.","year":"1970","journal-title":"Br. J. Vener. Dis."},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)92467-3"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)92466-1"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198509053131004"},{"key":"e_1_2_7_13_2","first-page":"563","article-title":"Tetracycline\u2010resistant Neisseria gonorrhoeae\u2014Georgia, Pennsylvania, New Hampshire","volume":"34","author":"Centers for Disease Control (CDC)","year":"1985","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1994.tb01297.x"},{"key":"e_1_2_7_15_2","first-page":"90","article-title":"High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan","volume":"70","author":"Tanaka M.","year":"1994","journal-title":"Genitourin. Med."},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/430787"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.9.2200"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0301.970104"},{"key":"e_1_2_7_19_2","first-page":"833","article-title":"Fluoroquinolone\u2010resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999","volume":"49","author":"Centers for Disease Control and Prevention (CDC)","year":"2000","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"e_1_2_7_20_2","first-page":"1041","article-title":"Increases in fluoroquinolone\u2010resistant Neisseria gonorrhoeae\u2014Hawaii and California, 2001","volume":"51","author":"Centers for Disease Control and Prevention (CDC)","year":"2002","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"e_1_2_7_21_2","first-page":"335","article-title":"Increases in fluoroquinolone\u2010resistant Neisseria gonorrhoeae among men who have sex with men\u2014United States, 2003, and revised recommendations for gonorrhea treatment, 2004","volume":"53","author":"Centers for Disease Control and Prevention (CDC)","year":"2004","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-011-0169-9"},{"key":"e_1_2_7_23_2","first-page":"332","article-title":"Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656560902731993"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.042648"},{"key":"e_1_2_7_26_2","volume-title":"Antimicrobial resistance in Neisseria gonorrhoeae WHO\/CDS\/CSR\/DRS\/2001.3","author":"Tapsall J.W.","year":"2001"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-002-0204-8"},{"key":"e_1_2_7_28_2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":"Threat to cefixime treatment of gonorrhea","volume":"13","author":"Yokoi S.","year":"2007","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_2_7_29_2","doi-asserted-by":"crossref","first-page":"ii19721","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first\u2010line cefixime for gonorrhoea treatment, Norway, 2010","volume":"15","author":"Unemo M.","year":"2010","journal-title":"Euro. Surveill."},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1701.100397"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00325-11"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.1.210-212.2000"},{"key":"e_1_2_7_33_2","first-page":"123","article-title":"Intraspecific and intergeneric mobilization of non\u2010conjugative resistance plasmids by a 24.5 megadalton conjugative plasmid of Neisseria gonorrhoeae","volume":"125","author":"Flett F.","year":"1981","journal-title":"J. Gen. Microbiol."},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.1986.tb03000.x"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.2.Suppl.S18"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.9.1430"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.11.3.528"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.5.649"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1989.tb00101.x"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/128.3.321"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1099\/13500872-141-3-611"},{"key":"e_1_2_7_42_2","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.43.10.2468","article-title":"Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations","volume":"43","author":"Zarantonelli L.","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.184.20.5619-5624.2002"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.11.2799"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.9.2811-2820.2002"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.188.7.2300-2308.2006"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.188.7.2297-2299.2006"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.769-777.2002"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2005.04752.x"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.12.3744-3749.2002"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2010.045377"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.1.137-143.2005"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp505"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01604-06"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00406-09"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00626-06"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2005.08.021"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi101167x"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp098"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00306-07"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00304-09"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq377"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.4.1829"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-143-7-2117"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2008.06424.x"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.10.5576-5582.2003"},{"key":"e_1_2_7_67_2","doi-asserted-by":"publisher","DOI":"10.1086\/522964"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00010-11"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00005-11"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00067-11"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq289"},{"key":"e_1_2_7_72_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198707303170504"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1086\/511422"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq476"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh272"},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867013371743"},{"key":"e_1_2_7_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2010.11.011"},{"key":"e_1_2_7_78_2","unstructured":"Mao H. P.Zhou&R.A.Nicholas.2010.LpxC inhibitors as a novel class of antibiotics againstNeisseria gonorrhoeae. InProceedings of the 17thInternational Pathogenic Neisseria Conference Banff Alberta Canada. Abstr. P011."},{"key":"e_1_2_7_79_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-009-0057-2"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2011.06215.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2011.06215.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T08:48:05Z","timestamp":1741769285000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2011.06215.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1111\/j.1749-6632.2011.06215.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2011.06215.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}